Spain
Integra Therapeutics, founded in 2020, is a pioneering biotech company headquartered in Spain. With the slogan, "Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases," the company is at the forefront of developing cutting-edge gene writing technology.
Integra Therapeutics has ingeniously combined the well-documented precision of CRISPR systems with the exceptional gene transfer efficiency offered by viral integrases and transposases. This fusion of advanced technologies allows the company to precisely and efficiently integrate large DNA sequences into genomes, marking a breakthrough in programmable gene delivery.
Recently, the company reinforced its stronghold in the industry with a €10.70M seed investment round on 01 September 2025. Notable investors include Columbus Venture Partners, Takeda Ventures, Invivo Partners, AdBio partners, EIC Fund, and CDTI Innvierte, showcasing significant confidence in Integra Therapeutics' potential to revolutionize genetic therapies.
